These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35832325)

  • 21. The effect of a live Neospora caninum tachyzoite vaccine in naturally infected pregnant dairy cows.
    Mazuz ML; Fish L; Wolkomirsky R; Leibovich B; Reznikov D; Savitsky I; Golenser J; Shkap V
    Prev Vet Med; 2015 Jun; 120(2):232-235. PubMed ID: 25890821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of a DIVA-like recombinant vaccine composed by rNcSAG1 and rAtHsp81.2 against vertical transmission in a mouse model of congenital neosporosis.
    Bengoa-Luoni SA; Corigliano MG; Sánchez-López E; Albarracín RM; Legarralde A; Ganuza A; Clemente M; Sander VA
    Acta Trop; 2019 Oct; 198():105094. PubMed ID: 31323195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of attenuated Neospora caninum by long-term passages on murine macrophage cell line in prevention of vertical transmission in mice.
    Amini L; Namavari M; Khodakaram-Tafti A; Divar MR; Hosseini SMH
    Vet Parasitol; 2020 Jul; 283():109171. PubMed ID: 32623187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of dense granule antigen 7 in vertical transmission of Neospora caninum in C57BL/6 mice infected during early pregnancy.
    Abdou AM; Ikeda R; Watanabe K; Furuoka H; Nishikawa Y
    Parasitol Int; 2022 Aug; 89():102576. PubMed ID: 35301119
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Abdelbaky HH; Rahman MM; Shimoda N; Chen Y; Hasan T; Ushio N; Nishikawa Y
    Front Microbiol; 2023; 14():1334447. PubMed ID: 38260884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
    Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.
    Müller J; Aguado-Martínez A; Ortega-Mora LM; Moreno-Gonzalo J; Ferre I; Hulverson MA; Choi R; McCloskey MC; Barrett LK; Maly DJ; Ojo KK; Van Voorhis W; Hemphill A
    J Antimicrob Chemother; 2017 Aug; 72(8):2334-2341. PubMed ID: 28486633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model.
    Arranz-Solís D; Aguado-Martínez A; Müller J; Regidor-Cerrillo J; Ortega-Mora LM; Hemphill A
    Vet Parasitol; 2015 Jul; 211(3-4):133-40. PubMed ID: 26104964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
    Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of vaccination with Neospora caninum protein for prevention of fetal loss associated with experimentally induced neosporosis in sheep.
    Jenkins MC; Tuo W; Dubey JP
    Am J Vet Res; 2004 Oct; 65(10):1404-8. PubMed ID: 15524328
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Winzer P; Müller J; Imhof D; Ritler D; Uldry AC; Braga-Lagache S; Heller M; Ojo KK; Van Voorhis WC; Ortega-Mora LM; Hemphill A
    Microorganisms; 2020 May; 8(6):. PubMed ID: 32466554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
    Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
    J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
    Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Jiménez-Ruíz E; Alvarez-García G
    Vaccine; 2011 Oct; 29(44):7867-74. PubMed ID: 21816191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy.
    Sánchez-Sánchez R; Ferre I; Re M; Ramos JJ; Regidor-Cerrillo J; Pizarro Díaz M; González-Huecas M; Tabanera E; Benavides J; Hemphill A; Hulverson MA; Barrett LK; Choi R; Whitman GR; Ojo KK; Van Voorhis WC; Ortega-Mora LM
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice.
    Rojo-Montejo S; Collantes-Fernández E; López-Pérez I; Risco-Castillo V; Prenafeta A; Ortega-Mora LM
    Vet Res; 2012 Aug; 43(1):62. PubMed ID: 22913428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
    Alaeddine F; Keller N; Leepin A; Hemphill A
    J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Neospora caninum infection in BALB/c mice during pregnancy in post-natal development.
    López-Pérez IC; Collantes-Fernández E; Aguado-Martínez A; Rodríguez-Bertos A; Ortega-Mora LM
    Vet Parasitol; 2008 Aug; 155(3-4):175-83. PubMed ID: 18586405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Neospora caninum intra-specific variability in the outcome of infection in a pregnant BALB/c mouse model.
    Regidor-Cerrillo J; Gómez-Bautista M; Del Pozo I; Jiménez-Ruiz E; Aduriz G; Ortega-Mora LM
    Vet Res; 2010; 41(4):52. PubMed ID: 20416260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neospora caninum antigens displaying virus-like particles as a bivalent vaccine candidate against neosporosis.
    Xu J; Hiramatsu R; Suhaimi H; Kato T; Fujimoto A; Tokiwa T; Ike K; Park EY
    Vaccine; 2019 Oct; 37(43):6426-6434. PubMed ID: 31515150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.